16 / April / 2024 Immunotherapy using checkpoint inhibitors brings new hope to many cancer patients, but there is a need for improvement Research focuses on understanding immune mechanisms behind anti-tumor immune responses in oncology patient volunteers Por Kenneth J. Gollob*
